Eliphos
These highlights do not include all the information needed to use ELIPHOS Tablets safely and effectively. See full prescribing information for ELIPHOS Tablets. ELIPHOS Tablets (calcium acetate): 667 mg Initial U.S. Approval: 1990
Approved
Approval ID
9fc1ada4-9ef4-48e9-8203-32aa857d0429
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Aug 6, 2016
Manufacturers
FDA
Carilion Materials Management
DUNS: 079239644
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Calcium Acetate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code68151-5204
Application NumberANDA078502
Product Classification
M
Marketing Category
C73584
G
Generic Name
Calcium Acetate
Product Specifications
Route of AdministrationORAL
Effective DateSeptember 3, 2015
FDA Product Classification
INGREDIENTS (1)
CALCIUM ACETATEActive
Quantity: 667 mg in 1 1
Code: Y882YXF34X
Classification: ACTIB